Tim Marquart

Person

Mountain View, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
A2B adenosine receptor antagonists
- Patent number 7,521,554
- Issue date Apr 21, 2009
- CV Therapeutics, Inc.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine rec...
- Patent number 7,449,473
- Issue date Nov 11, 2008
- CV Therapeutics, Inc.
- Rao Kalla
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic compounds
- Patent number 7,208,496
- Issue date Apr 24, 2007
- CV Therapeutics, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
A2B adenosine receptor antagonists
- Patent number 7,125,993
- Issue date Oct 24, 2006
- CV Therapeutics, Inc.
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic compounds
- Patent number 7,026,321
- Issue date Apr 11, 2006
- CV Therapeutics, Inc.
- Robert Jiang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aralkyl substituted piperazine compounds
- Patent number 6,852,723
- Issue date Feb 8, 2005
- CV Therapeutics, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted piperazine compounds
- Patent number 6,677,336
- Issue date Jan 13, 2004
- CV Therapeutics, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted alkylene diamine compounds
- Patent number 6,638,970
- Issue date Oct 28, 2003
- CV Therapeutics, Inc.
- Elfaith Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Aralkyl substituted piperazine compounds
- Patent number 6,552,023
- Issue date Apr 22, 2003
- CV Therapeutics, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
A2B ADENOSINE RECEPTOR ANTAGONISTS
- Publication number 20090137802
- Publication date May 28, 2009
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED HETEROCYCLIC COMPOUNDS
- Publication number 20070191390
- Publication date Aug 16, 2007
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A2B adenosine receptor antagonists
- Publication number 20060281921
- Publication date Dec 14, 2006
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A2B adenosine receptor antagonists
- Publication number 20050119287
- Publication date Jun 2, 2005
- Rao Kalla
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted heterocyclic compounds
- Publication number 20050049254
- Publication date Mar 3, 2005
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted heterocyclic compounds
- Publication number 20040186109
- Publication date Sep 23, 2004
- Robert Jiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
A2B adenosine receptor antagonists
- Publication number 20040176399
- Publication date Sep 9, 2004
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aralkyl substituted piperazine compounds
- Publication number 20030176440
- Publication date Sep 18, 2003
- CV Therapeutics, Inc.
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted piperazine compounds
- Publication number 20020016463
- Publication date Feb 7, 2002
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Aralkyl substituted piperazine compounds
- Publication number 20010041704
- Publication date Nov 15, 2001
- Jeff Zablocki
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted alkylene diamine compounds
- Publication number 20010036961
- Publication date Nov 1, 2001
- Elfatih Elzein
- C07 - ORGANIC CHEMISTRY

Tim Marquart

Person

Patents Grantslast 30 patents

A2B adenosine receptor antagonists

Substituted pyrrolo[3,2-d]pyrimidin-2,4-diones as A2b adenosine rec...

Substituted heterocyclic compounds

A2B adenosine receptor antagonists

Substituted heterocyclic compounds

Aralkyl substituted piperazine compounds

Substituted piperazine compounds

Substituted alkylene diamine compounds

Aralkyl substituted piperazine compounds

Patents Applicationslast 30 patents

A2B ADENOSINE RECEPTOR ANTAGONISTS

SUBSTITUTED HETEROCYCLIC COMPOUNDS

A2B adenosine receptor antagonists

A2B adenosine receptor antagonists

Substituted heterocyclic compounds

Substituted heterocyclic compounds

A2B adenosine receptor antagonists

Aralkyl substituted piperazine compounds

Substituted piperazine compounds

Aralkyl substituted piperazine compounds

Substituted alkylene diamine compounds